Skip to content

13F-HR filed by Carlyle Group Inc.

Carlyle Group Inc. filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-09, with 31 holding rows worth $1,052,989,648.

Accession
0000898432-24-000692
Filed
2024-08-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A combination report, 31 entries on the cover page, a total value of $1,052,989,648 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,052,989,648 with VALUE read as dollars as filed, 13F file number 028-15025. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
QUIDELORTHO CORP COM219798105Stock11,520,751$382,719,348dollars as filed
ZOOMINFO TECHNOLOGIES INC COMMON STOCK98980F104Stock17,244,747$220,215,419dollars as filed
SOLENO THERAPEUTICS INC834203309COM4,071,562$166,364,023dollars as filed
GDS HLDGS LTD SPONSORED ADS36165L108ADR4,072,624$37,834,677dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK3,496,808$35,842,282dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS2,457,500$35,510,875dollars as filed
GETTY IMAGES HOLDINGS INC374275105CL A COM9,212,799$30,033,726dollars as filed
HILLEVAX INC43157M102COM1,838,486$26,437,429dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW1,066,189$24,202,490dollars as filed
Q32 BIO INC746964105Common Stock1,102,741$19,198,721dollars as filed
SEACOR MARINE HLDGS INC COM78413P101Stock1,314,164$17,728,072dollars as filed
INVITATION HOMES INC COM46187W107REIT477,500$17,137,475dollars as filed
CUBESMART COM229663109REIT220,500$9,959,985dollars as filed
SUNPOWER INC20460L104COM4,936,483$5,479,496dollars as filed
RENEO PHARMACEUTICALS INC75974E103COM2,698,957$4,156,394dollars as filed
SMART SH GLOBAL LTD83193E102ADS4,810,209$4,130,045dollars as filed
KRISPY KREME INC50101L106COMMON STOCK340,748$3,666,448dollars as filed
ADICET BIO INC007002108COM2,948,718$3,597,436dollars as filed
SPRUCE BIOSCIENCES INC85209E109COM2,896,518$1,520,093dollars as filed
AON PLC SHS CL AG0403H108Stock4,973$1,459,973dollars as filed
N-ABLE INC COMMON STOCK62878D100Stock93,732$1,427,538dollars as filed
Broadcom Inc.11135F101COM755$1,212,032dollars as filed
SOLARWINDS CORP83417Q204COM NEW93,735$1,129,507dollars as filed
NU HLDGS LTDG6683N103ORD SHS CL A55,417$714,325dollars as filed
DOORDASH INC CL A25809K105Stock4,156$452,090dollars as filed
NuCana PLC67022C205Depositary Receipt133,333$339,999dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW9,620$226,936dollars as filed
META DATA LIMITED68276W400SPONSORED ADS314,400$133,306dollars as filed
EXICURE INC30205M200COM NEW281,636$88,772dollars as filed
EFFECTOR THERAPEUTIC EQUCLASS EQUITY28202V207COMMON STOCK192,884$55,936dollars as filed
MOLECULAR TEMPLATES INC608550208COM13,333$14,800dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000898432-24-000692this filing2024-08-09acceptance time not in the bulk data set